TSX-V:SQD - TSX Venture Exchange - CA78466B1085 - Common Stock - Currency: CAD
TSX-V:SQD (6/14/2023, 7:00:00 PM)
0.015
0 (0%)
The current stock price of SQD.CA is 0.015 CAD. In the past month the price decreased by -76.92%. In the past year, price decreased by -91.18%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 297.70M | ||
MIR.CA | MEDMIRA INC | N/A | 79.62M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 61.95M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 50.50M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 33.97M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 28.76M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 27.68M | ||
ASG.CA | AURORA SPINE CORP | N/A | 24.90M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 17.70M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 15.91M | ||
EVMT.CA | EVOME MEDICAL TECHNOLOGIES I | N/A | 4.81M |
SQI Diagnostics, Inc. engages in developing and selling testing kits, services, and automated testing systems to clinical laboratories, hospitals, clinicians, and diagnostic testing companies. The company is headquartered in Etobicoke, Ontario. The company went IPO on 2005-02-09. The firm develops and manufactures respiratory health and precision medicine tests that run on structured query language (SQI) fully automated systems. Its tests enhance COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its COVID-19 testing solutions include Rapid Mobile PCR Testing for COVID-19, Sofia SARS Antigen Fluorescent Immunoassay (FIA) and Sofia2 Flu+SARS Antigen Fluorescent Immunoassay (FIA). Its transplant diagnostics solutions include TORdx LUNG Test, which is a diagnostic that assesses the health of donor lungs, and Ex Vivo Lung Perfusion provides care for conditioning donor lungs suspected of injury prior to transplantation. The company also offers surveillance testing such as Celiac Disease Screening Test and Rheumatoid Arthritis Test.
SQI DIAGNOSTICS INC
36 Meteor Dr
Etobicoke ONTARIO M9W 1A4 CA
CEO: Rob Chioini
Employees: 0
Company Website: https://sqidiagnostics.com/
Phone: 14166749500.0
The current stock price of SQD.CA is 0.015 CAD.
The exchange symbol of SQI DIAGNOSTICS INC is SQD and it is listed on the TSX Venture Exchange exchange.
SQD.CA stock is listed on the TSX Venture Exchange exchange.
SQI DIAGNOSTICS INC (SQD.CA) has a market capitalization of 6.11M CAD. This makes SQD.CA a Nano Cap stock.
SQI DIAGNOSTICS INC (SQD.CA) currently has 0 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SQD.CA does not pay a dividend.
SQI DIAGNOSTICS INC (SQD.CA) will report earnings on 2022-01-26.
SQI DIAGNOSTICS INC (SQD.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
ChartMill assigns a fundamental rating of 1 / 10 to SQD.CA. SQD.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months SQD.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS decreased by -16.39% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |